Cerevel Therapeutics Holdings, Inc.
USD44.96
+0.33 (+0.74%)
CEO
Ronald C. Renaud Jr.,
IPO Date
2020-07-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$44.98
Prev. Close
$44.63
Day Low
$44.96
Day High
$44.99
52W Low
$19.59
52W High
$44.99
Market Cap
$8.19B
Volume
15.03M
| -13.6 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -38.4% | -32.3% | 0.06 | 13.59 | -19.9 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -39.6% | -34.2% | 0.09 | 13.22 | -12.9 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -165.0% | -106.3% | 0.37 | 5.85 | -11.8 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 0.0% | 0.0% | 0.00 | 0.00 | -1.8 |
| 31 Aug 2015 | FY | -93.6% | -1035.1% | -668.3% | -2076.4% | 1.04 | 1.87 | -6.0 |
| 31 Aug 2014 | FY | -25.7% | -1219.7% | -106.2% | -947.4% | 0.00 | 6.21 | -5.8 |
| 31 Aug 2013 | FY | -19.1% | -620.1% | -98.5% | -685.6% | 0.01 | 8.12 | -5.2 |
| 31 Aug 2012 | FY | 55.6% | -547.6% | -47.0% | -42.5% | 0.01 | 9.08 | -5.8 |
| -14.0 |
| 30 Sept 2023 | Q3 | 0.0% | 0.0% | -35.3% | -11.7% | 1.34 | 8.72 | -8.9 |
| 30 Jun 2023 | Q2 | 0.0% | 0.0% | -28.4% | -11.1% | 1.04 | 11.47 | -12.5 |
| 31 Mar 2023 | Q1 | 0.0% | 0.0% | -24.2% | -11.2% | 0.85 | 13.35 | -9.2 |
| 31 Dec 2022 | Q4 | 0.0% | 0.0% | -17.8% | -9.1% | 0.70 | 12.48 | -13.3 |
| 30 Sept 2022 | Q3 | 0.0% | 0.0% | -17.4% | -9.6% | 0.61 | 16.64 | -10.3 |
| 30 Jun 2022 | Q2 | 0.0% | 0.0% | -20.0% | -15.2% | 0.08 | 9.52 | -10.8 |
| 31 Mar 2022 | Q1 | 0.0% | 0.0% | -12.3% | -10.4% | 0.07 | 15.67 | -20.2 |
| 31 Dec 2021 | Q4 | 0.0% | 0.0% | -10.2% | -8.6% | 0.06 | 13.59 | -20.2 |